CompletedPhase 2NCT01303146

Efficacy METAZYM for the Treatment Metachromatic Leukodystrophy Treated With Hematopoietic Stem Cell Transplantation

Studying Metachromatic leukodystrophy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Patrick Aubourg, MD, PhD
Department of Pediatric Endocrinology and Neurology, Saint Vincent de Paul Hospital, Paris
Intervention
rhARSA(drug)
Enrollment
1 enrolled
Eligibility
All sexes
Timeline
2008 – 2010

Study locations (1)

Collaborators

European Leukodystrophy Association · Zymenex A/S · Shire · URC-CIC Paris Descartes Necker Cochin

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01303146 on ClinicalTrials.gov

Other trials for Metachromatic leukodystrophy

Additional recruiting or active studies for the same condition.

See all trials for Metachromatic leukodystrophy →

← Back to all trials